[Resistance to oral sugar-reducing therapy in patients with insulin-dependent diabetes mellitus]. 1991

N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
January 1983, The American journal of medicine,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
December 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
August 1986, Scandinavian journal of dental research,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
May 1991, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
January 1987, Diabetes care,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
January 1992, Experimental and clinical endocrinology,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
March 1987, The Medical journal of Australia,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
April 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
June 1981, The Journal of pediatrics,
N A Almagambetova, and I M Belovalova, and A A Perelygina, and L K Starosel'tseva
October 1999, Endocrine journal,
Copied contents to your clipboard!